We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.88%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.12B
AUM Growth
+$596M
Cap. Flow
+$91.3M
Cap. Flow %
1.28%
Top 10 Hldgs %
11.77%
Holding
645
New
72
Increased
209
Reduced
241
Closed
76

Top Sells

Rank Stock Value
1
REVG
REV Group
REVG
+$46.8M
2
UNH icon
UnitedHealth
UNH
+$43.8M
3
AZEK
The AZEK Co
AZEK
+$23.3M
4
MCK icon
McKesson
MCK
+$21.1M
5
TJX icon
TJX Companies
TJX
+$17.8M

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Industrials 18.36%
3 Financials 15.32%
4 Healthcare 12.69%
5 Consumer Discretionary 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHRW icon
226
C.H. Robinson
CHRW
$17.4B
$10.1M 0.14%
105,751
-18,912
-15% -$1.77M
GERN icon
227
Geron
GERN
$828M
$10.1M 0.14%
7,192,184
-234,670
-3% -$333K
BSX icon
228
Boston Scientific
BSX
$69.5B
$10.1M 0.14%
94,097
+12,477
+15% +$1.26M
CBRE icon
229
CBRE Group
CBRE
$42.5B
$10.1M 0.14%
71,980
-5,033
-7% -$636K
GH icon
230
Guardant Health
GH
$21.5B
$10.1M 0.14%
+193,325
New +$8.63M
CRDO icon
231
Credo Technology Group
CRDO
$38.6B
$10M 0.14%
108,298
+18,435
+21% +$1.08M
GSHD icon
232
Goosehead Insurance
GSHD
$2.2B
$9.98M 0.14%
94,547
+16,146
+21% +$1.71M
ICHR icon
233
Ichor Holdings
ICHR
$2.62B
$9.94M 0.14%
506,257
-6,631
-1% -$121K
IOSP icon
234
Innospec
IOSP
$2.12B
$9.94M 0.14%
118,161
+20,220
+21% +$1.77M
USFD icon
235
US Foods
USFD
$22.2B
$9.92M 0.14%
128,768
+7,898
+7% +$563K
SLAB icon
236
Silicon Laboratories
SLAB
$7.17B
$9.76M 0.14%
66,256
+2,232
+3% +$264K
FTAI icon
237
FTAI Aviation
FTAI
$21.1B
$9.58M 0.13%
83,247
+14,246
+21% +$1.59M
GWRE icon
238
Guidewire Software
GWRE
$12.6B
$9.49M 0.13%
40,324
-37,220
-48% -$8M
HP icon
239
Helmerich & Payne
HP
$3.45B
$9.49M 0.13%
626,199
-15,795
-2% -$290K
SMG icon
240
ScottsMiracle-Gro
SMG
$3.82B
$9.34M 0.13%
+141,553
New +$8.18M
MD icon
241
Pediatrix Medical
MD
$2.18B
$9.31M 0.13%
648,677
-86,109
-12% -$1.18M
CHD icon
242
Church & Dwight Co
CHD
$23.4B
$9.26M 0.13%
96,317
-6,572
-6% -$648K
VAL icon
243
Valaris
VAL
$5.48B
$9.25M 0.13%
219,753
-6,602
-3% -$248K
QGEN icon
244
Qiagen
QGEN
$8.54B
$9.17M 0.13%
190,738
+15,082
+9% +$656K
ASTE icon
245
Astec Industries
ASTE
$1.16B
$9.01M 0.13%
216,066
+17,056
+9% +$648K
VOO icon
246
Vanguard S&P 500 ETF
VOO
$979B
$8.96M 0.13%
15,777
-2,369
-13% -$1.25M
GLOB icon
247
Globant
GLOB
$1.58B
$8.86M 0.12%
97,588
+9,358
+11% +$999K
COCO icon
248
Vita Coco
COCO
$3.82B
$8.74M 0.12%
242,015
+41,506
+21% +$1.39M
SAIA icon
249
Saia
SAIA
$9.25B
$8.67M 0.12%
31,655
+5,431
+21% +$1.55M
TMO icon
250
Thermo Fisher Scientific
TMO
$213B
$8.64M 0.12%
21,316
-1,406
-6% -$588K

Similar funds

Segall Bryant & Hamill's Q2 2025 Portfolio in Review

As of Q2 2025, Segall Bryant & Hamill held 645 positions worth $7.12B, up 9.1% from $6.53B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill's Q2 2025 filing shows 72 new, 209 increased, 241 reduced and 76 closed positions. Its largest new stake was Flowserve: 345,600 shares worth $18.1M. The largest sale was REV Group, an estimated $46.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q2 2025 buy was Flowserve: 345,600 shares worth $18.1M.
  • Segall Bryant & Hamill added most to Meta Platforms (Facebook) in Q2 2025, an estimated $28.6M increase.
  • Segall Bryant & Hamill's biggest Q2 2025 reduction was REV Group, cutting an estimated $46.8M.
  • Segall Bryant & Hamill fully exited UnitedHealth in Q2 2025, selling an estimated $43.8M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $7.12B portfolio in Q2 2025.
  • Segall Bryant & Hamill opened 72 new positions and closed 76 in Q2 2025.
  • Segall Bryant & Hamill's portfolio value rose 9.1% quarter-over-quarter to $7.12B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2025, filed 12 Aug 2025.